Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 2726 results found since Jan 2013.
CDC: Proposed Data Collection Submitted for Public Comment and Recommendations
Notice from the Centers for Disease Control and Prevention (CDC) seeking comments on a proposed information collection project titled "National Healthcare Safety Network (NHSN) Coronavirus (COVID-19) Surveillance in Healthcare Facilities." The information collected through this version of NHSN is intended to inform the federal government's understanding of disease patterns, including the changing burden of disease, and develop policies for the prevention and control of problems related to COVID-19. Comments are due by November 14, 2022.
Source: Federal Register updates via the Rural Assistance Center - September 12, 2022 Category: Rural Health Source Type: news
Will the COVID-19 booster be like an annual flu shot?
The Centers for Disease Control and Prevention (CDC) recently released new recommendations for COVID-19 booster vaccinations. The shots, called bivalent vaccines, are designed to protect people from the original coronavirus strain and highly contagious omicron subvariants. The CDC recommends that everyone 12 and older get the updated booster. "All of the other components are the same, so it works the exact same way at inducing an immune response. It's just that now this immune response…
Source: News from Mayo Clinic - September 12, 2022 Category: Databases & Libraries Source Type: news
Weekly Overseas Health IT Links –10th September, 2022.
This article is adapted fromVoices in the Code: A Story About People, Their Values, and the Algorithm They Made,out Sept. 8 from Russell Sage Foundation Press.In May 2021, I got a call I never expected. I was working on abook about A.I. ethics, focused on the algorithm that gives out kidneys to transplant patients in the United States. Darren Stewart —a data scientist from UNOS, the nonprofit that runs the kidney allocation process—was calling to get my take: How many decimal places should they include when calculating each patient’s allocation score? The score is an incredibly important number, given it determines w...
Source: Australian Health Information Technology - September 10, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
New private venture tackles the riddle of Long Covid —and aims to test treatments quickly
A new, privately funded venture announced today it has recruited more than 20 top scientists and is pouring $15 million raised so far into Long Covid research, with plans to launch clinical trials of treatments as soon as possible. The scientist who spearheaded the Long Covid Research Initiative (LCRI), microbiologist Amy Proal at the Washington state–based nonprofit PolyBio Research Foundation, says the goal is to bring in $100 million. Half would be dedicated to trials, which have thus far been sparse in the field.
When it comes to available funds, LCRI pales in comparison with the behemoth RECOVER initiative at t...
Source: Science of Aging Knowledge Environment - September 8, 2022 Category: Geriatrics Source Type: research
Who should get the updated coronavirus vaccine booster now?
The US Centers for Disease Control and Prevention has this month greenlit the rollout of updated Covid-19 vaccine boosters, following the US Food and Drug Administration's authorization. These shots will replace the boosters previously offered in the US such that, for people 12 and older, being "up-to-date" with vaccines means having the new jab.
Source: CNN.com - Health - September 8, 2022 Category: Consumer Health News Source Type: news
Who should get the updated coronavirus vaccine booster now—and who should wait?
The US Centers for Disease Control and Prevention has this month greenlit the rollout of updated Covid-19 vaccine boosters, following the US Food and Drug Administration's authorization. These shots will replace the boosters previously offered in the US such that, for people 12 and older, being "up-to-date" with vaccines means having the new jab.
Source: CNN.com - Health - September 8, 2022 Category: Consumer Health News Source Type: news
Researchers Are Now Tracking Monkeypox in Wastewater
If the past two years have taught us anything, it’s that testing for viral diseases is complicated. Sometimes, the tests are difficult to get, like in the early days of COVID-19. And even if people have access to testing, they might not feel they need it. People with COVID-19 often don’t have symptoms and may not always know to get tested. And now, with the availability of at-home self-tests, most people test themselves and don’t report the results. With other diseases—such as monkeypox—stigma surrounding the disease and the group most affected can deter access to testing.
These limitations hi...
Source: TIME: Health - September 7, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate monkeypox Source Type: news
CDC Signs Off on Updated Booster Shots That Address Omicron
The debut of Omicron-specific vaccines raises a thorny question: How long should you wait between shots?
Source: NYT Health - September 2, 2022 Category: Consumer Health News Authors: Benjamin Mueller Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Viruses Centers for Disease Control and Prevention your-feed-healthcare Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I'm not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I’m not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
Facial Flap Necrosis From COVID-19 Face Mask Precautions
Abstract:
Use of facial mask coverings has been a strong Centers for Disease Control and Prevention recommendation as an essential mitigation measure in the spread of the SARS-CoV-2 novel coronavirus (COVID)-19 virus. Face mask utilization has been shown to induce changes in the skin microclimate, especially around the perioral and perinasal regions. This results in increased mask adjustments and development of friction between masks and the underlying skin. The authors report novel findings of 2 individuals with skin cancer who underwent facial reconstruction during the COVID-19 pandemic. They encountered untoward seq...
Source: Journal of Craniofacial Surgery - September 1, 2022 Category: Surgery Tags: Clinical Studies Source Type: research
FDA Authorizes Updated Covid Boosters That Target Newest Variants
WASHINGTON — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days.
The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope is that the modified boosters will blunt yet another winter surge.
“You’ll see me at the front of the line,” FDA vaccine chief Dr. Peter Marks told The Associated Press shortly before his agency cleared the new doses.
Until now, COVID-19 vaccines have targeted the ...
Source: TIME: Health - August 31, 2022 Category: Consumer Health News Authors: Lauran Neergaard/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Building cognitive reserve helps delay memory and thinking decline regardless of genetic or childhood markers
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring timely brain news and a few fun brain teasers to test your perceptual and cognitive skills.
#1. Study: Building cognitive reserve helps delay memory and thinking decline regardless of genetic or childhood markers
“While our childhood can influence our memory and thinking skills later in life, this research underlines the message that it’s never too late to take action to support cognitive health.” — Dr Sara Imarisio, Head of Strategic Initiatives at Alzheimer’s Research UK
#2. Fully-automated analysis of voice recordings–from neuropsychologica...
Source: SharpBrains - August 30, 2022 Category: Neuroscience Authors: SharpBrains Tags: Brain Teasers Brain/ Mental Health Education & Lifelong Learning SharpBrains Monthly eNewsletter Technology & Innovation Akili Interactive Labs antidepressants cognitive behaviour therapy cognitive-health cognitive-reserve dementia d Source Type: blogs
Moderna Is Seeking FDA Authorization for Its Omicron Booster
Moderna Inc. completed its filing to request U.S. clearance for a booster shot that targets the latest Omicron COVID variants, a move to provide more protection against the persistent coronavirus.
In a statement, the company said it had wrapped up the submission for emergency authorization for the company’s bivalent COVID booster vaccine that targets the BA.4 and BA.5 strains along with the original version of COVID. The filing includes preclinical data for the booster against the latest strains, along with clinical data from the company’s other bivalent booster that targets the original Omicron strain.
Moderna...
Source: TIME: Health - August 24, 2022 Category: Consumer Health News Authors: Robert Langreth/Bloomberg Tags: Uncategorized COVID-19 healthscienceclimate Vaccines wire Source Type: news
Biden Administration Plans for Booster Shot Campaign in September
A top F.D.A. regulator cited compelling data for redesigned coronavirus vaccines from Pfizer-BioNTech and Moderna.
Source: NYT - August 24, 2022 Category: American Health Authors: Sharon LaFraniere and Noah Weiland Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Omicron Variant Food and Drug Administration Centers for Disease Control and Prevention Pfizer Inc Moderna Inc Fauci, Anthony S Marks, Peter Source Type: news
